Freeline Therapeutics Limited

Freeline Therapeutics Limited

Freeline Therapeutics Limited

Freeline is a biopharmaceutical company focused on the development and commercialisation of gene therapies for bleeding and other debilitating disorders based on a nextgeneration AAV gene therapy platform developed by Amit Nathwani, Professor of Haematolo
Founded
2015
Raised
$39.5M
Follow us
Alexa global traffic share
Latest funding
£1,000,000
Venture capital (Series A) - 2016
UCL Technology Fund
Team Size
10+
Employees
£1,000,000 Venture capital (Series A)
UCLB

UCL Technology Fund makes £1 million investment in gene therapy company, Freeline Therapeutics

Health Science Funding